GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » YoY Rev. per Sh. Growth

Oncimmune Holdings (LSE:ONC) YoY Rev. per Sh. Growth : 0.00% (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Oncimmune Holdings's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 was 0.00%.

Oncimmune Holdings's Revenue per Share for the six months ended in Feb. 2024 was £0.02.

Oncimmune Holdings YoY Rev. per Sh. Growth Historical Data

The historical data trend for Oncimmune Holdings's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncimmune Holdings YoY Rev. per Sh. Growth Chart

Oncimmune Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 Aug23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.00 166.67 625.00 -20.69 -65.22

Oncimmune Holdings Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Feb23 Aug23 Feb24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.59 -10.34 -23.81 -100.00 -

Oncimmune Holdings YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Oncimmune Holdings's YoY Rev. per Sh. Growth for the fiscal year that ended in Aug. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Aug. 2023 )
=(Revenue per Share (A: Aug. 2023 )-Revenue per Share (A: May. 2022 ))/ | Revenue per Share (A: May. 2022 ) |
=(0.016-0.046)/ | 0.046 |
=-65.22 %

Oncimmune Holdings's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Feb. 2024 )
=(Revenue per Share (Q: Feb. 2024 )-Revenue per Share (Q: Feb. 2023 )) / | Revenue per Share (Q: Feb. 2023 )) |
=(0.016-0.016)/ | 0.016 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncimmune Holdings YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
LSE:OPTI LSE:HEMO LSE:IXI LSE:APTA LSE:SNG LSE:FAB LSE:AREC LSE:CIZ LSE:GENF LSE:ROQ VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB
Website
https://www.oncimmune.com
Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection, and care of cancer. The company's operating segment is ImmunoINSIGHTS.